Navigation Links
AcelRx Pharmaceuticals to Present at the JMP Securities Research Conference
Date:5/6/2011

REDWOOD CITY, Calif., May 6, 2011 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and Chief Executive Officer, will present at The Tenth Annual JMP Securities Research Conference at the San Francisco Ritz Carlton. The presentation is scheduled for Monday, May 9, 2011 at 12:30p.m. PT.  

The presentation will be webcast live and can be accessed through http://wsw.com/webcast/jmp13/acrx/.  For those who are not available to listen to the live broadcast, the presentation will be archived and available through http://www.acelrx.com.

About AcelRx Pharmaceuticals, Inc.

Based in Redwood City, CA, AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain. AcelRx's lead product candidate, the ARX-01 Sufentanil NanoTab(TM) PCA System, which has completed Phase 2 clinical development, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia (IV PCA) which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the inherent potential for programming and delivery errors associated with the complexity of infusion pumps. AcelRx has two additional product candidates which have completed Phase 2 clinical development: ARX-02 for the treatment of cancer breakthrough pain, and ARX-03 for providing mild sedation, anxiety reduction and pain relief for patients undergoing painful procedures in a physician's office.


'/>"/>
SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results
2. AcelRx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
3. AcelRx Pharmaceuticals Announces Pricing of Its Initial Public Offering
4. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
5. AcelRx Announces Positive Phase 2 Results From a Study of ARX-02 Sufentanil NanoTab(TM) Breakthrough Pain Management System in Treating Cancer Breakthrough Pain
6. AcelRx to Present at the Lazard 6th Annual Healthcare Conference
7. AcelRx Programs to be Featured in Oral Presentations at the American Society of Anesthesiologists 2009 Annual Meeting
8. AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
9. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
10. AcelRx Pharmaceuticals Reports Positive Results from a Clinical Trial of Sublingual Sufentanil/Triazolam NanoTab(TM) Combination (ARX-03) in Treating Procedural Pain and Anxiety
11. Optimer Pharmaceuticals Reports First Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... 2016 --> ... "Pharmaceutical Packaging Equipment Market by Package Type (Blister, Strip, ... Product Type (Tablet, Powder, Cream, Syrup, Aseptic Liquid, Aerosol) ... global market during the forecast period of 2015 to ... CAGR of 6.9% during the forecast period to reach ...
(Date:2/10/2016)... aims to ensure 2,50,532 children between the ages ... th birthday   --> The campaign ... - 5 years reach the milestone of their 5 ... aims to ensure 2,50,532 children between the ages of 2 ... birthday   India , have launched the "Joy of Five" ...
(Date:2/9/2016)...  Insulet Corporation (NASDAQ: PODD ) (Insulet or the ... with its OmniPod ® Insulin Management System, ... appointed to Insulet,s Board of Directors. With his appointment, the ... are independent. --> --> ... experience and a deep knowledge of accounting, financial reporting and ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves with age, says ... to Brain Training" by award-winning author Phyllis Strupp explains how brain exercise ... 2016. A free review copy is available to the media at NetGalley . ...
(Date:2/10/2016)... ... February 10, 2016 , ... Everseat has joined the ... available to physicians. The integration will enable Allscripts users to post open appointments ... free mobile app. , The partnership gives Everseat substantial added power to help ...
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week announced the launch ... mounts ever. , “Our goal was to develop a product from the ground ... we have ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. “The ...
(Date:2/10/2016)... ... 2016 , ... Anxiety of older Americans over steep cost increases of prescription ... decade ago, according to The Senior Citizens League (TSCL). Since last ... with rapidly rising costs. “The implications are chilling, particularly for people with chronic ...
(Date:2/10/2016)... , ... February 09, 2016 , ... ... Clevens Face and Body Specialists are delighted to welcome a new addition to ... Clevens Face and Body Specialists as a nurse practitioner performing cosmetic procedures ...
Breaking Medicine News(10 mins):